663 related articles for article (PubMed ID: 26678028)
1. Biomedical applications of nisin.
Shin JM; Gwak JW; Kamarajan P; Fenno JC; Rickard AH; Kapila YL
J Appl Microbiol; 2016 Jun; 120(6):1449-65. PubMed ID: 26678028
[TBL] [Abstract][Full Text] [Related]
2. Bioengineering of the model lantibiotic nisin.
Field D; Cotter PD; Ross RP; Hill C
Bioengineered; 2015; 6(4):187-92. PubMed ID: 25970137
[TBL] [Abstract][Full Text] [Related]
3. Increasing the Antimicrobial Activity of Nisin-Based Lantibiotics against Gram-Negative Pathogens.
Li Q; Montalban-Lopez M; Kuipers OP
Appl Environ Microbiol; 2018 Jun; 84(12):. PubMed ID: 29625984
[TBL] [Abstract][Full Text] [Related]
4. Nisin resistance in Gram-positive bacteria and approaches to circumvent resistance for successful therapeutic use.
Barbosa AAT; de Melo MR; da Silva CMR; Jain S; Dolabella SS
Crit Rev Microbiol; 2021 May; 47(3):376-385. PubMed ID: 33689548
[TBL] [Abstract][Full Text] [Related]
5. Synergistic Antimicrobial Activity Between the Broad Spectrum Bacteriocin Garvicin KS and Nisin, Farnesol and Polymyxin B Against Gram-Positive and Gram-Negative Bacteria.
Chi H; Holo H
Curr Microbiol; 2018 Mar; 75(3):272-277. PubMed ID: 29058043
[TBL] [Abstract][Full Text] [Related]
6. A Bioengineered Nisin Derivative To Control Streptococcus uberis Biofilms.
Pérez-Ibarreche M; Field D; Ross RP; Hill C
Appl Environ Microbiol; 2021 Jul; 87(16):e0039121. PubMed ID: 34105992
[TBL] [Abstract][Full Text] [Related]
7. Effects of bacteriocins on methicillin-resistant Staphylococcus aureus biofilm.
Okuda K; Zendo T; Sugimoto S; Iwase T; Tajima A; Yamada S; Sonomoto K; Mizunoe Y
Antimicrob Agents Chemother; 2013 Nov; 57(11):5572-9. PubMed ID: 23979748
[TBL] [Abstract][Full Text] [Related]
8. On bacteriocin delivery systems and potential applications.
Arthur TD; Cavera VL; Chikindas ML
Future Microbiol; 2014; 9(2):235-48. PubMed ID: 24571075
[TBL] [Abstract][Full Text] [Related]
9. Bypassing lantibiotic resistance by an effective nisin derivative.
Zaschke-Kriesche J; Behrmann LV; Reiners J; Lagedroste M; Gröner Y; Kalscheuer R; Smits SHJ
Bioorg Med Chem; 2019 Aug; 27(15):3454-3462. PubMed ID: 31253534
[TBL] [Abstract][Full Text] [Related]
10. A bioengineered nisin derivative to control biofilms of Staphylococcus pseudintermedius.
Field D; Gaudin N; Lyons F; O'Connor PM; Cotter PD; Hill C; Ross RP
PLoS One; 2015; 10(3):e0119684. PubMed ID: 25789988
[TBL] [Abstract][Full Text] [Related]
11. The generation of nisin variants with enhanced activity against specific gram-positive pathogens.
Field D; Connor PM; Cotter PD; Hill C; Ross RP
Mol Microbiol; 2008 Jul; 69(1):218-30. PubMed ID: 18485077
[TBL] [Abstract][Full Text] [Related]
12. Bioengineered nisin A derivatives with enhanced activity against both Gram positive and Gram negative pathogens.
Field D; Begley M; O'Connor PM; Daly KM; Hugenholtz F; Cotter PD; Hill C; Ross RP
PLoS One; 2012; 7(10):e46884. PubMed ID: 23056510
[TBL] [Abstract][Full Text] [Related]
13. Studies with bioengineered Nisin peptides highlight the broad-spectrum potency of Nisin V.
Field D; Quigley L; O'Connor PM; Rea MC; Daly K; Cotter PD; Hill C; Ross RP
Microb Biotechnol; 2010 Jul; 3(4):473-86. PubMed ID: 21255345
[TBL] [Abstract][Full Text] [Related]
14. Nisin-A lantibiotic with immunomodulatory properties: A review.
Małaczewska J; Kaczorek-Łukowska E
Peptides; 2021 Mar; 137():170479. PubMed ID: 33359393
[TBL] [Abstract][Full Text] [Related]
15. Production and characterization of nisin-like peptide produced by a strain of Lactococcus lactis isolated from fermented milk.
Mitra S; Chakrabartty PK; Biswas SR
Curr Microbiol; 2005 Sep; 51(3):183-7. PubMed ID: 16059770
[TBL] [Abstract][Full Text] [Related]
16. Bio-Engineered Nisin with Increased Anti-
Field D; Considine K; O'Connor PM; Ross RP; Hill C; Cotter PD
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33801752
[TBL] [Abstract][Full Text] [Related]
17. Saturation mutagenesis of lysine 12 leads to the identification of derivatives of nisin A with enhanced antimicrobial activity.
Molloy EM; Field D; O' Connor PM; Cotter PD; Hill C; Ross RP
PLoS One; 2013; 8(3):e58530. PubMed ID: 23505531
[TBL] [Abstract][Full Text] [Related]
18. Antibacterial peptide nisin: a potential role in the inhibition of oral pathogenic bacteria.
Tong Z; Ni L; Ling J
Peptides; 2014 Oct; 60():32-40. PubMed ID: 25088158
[TBL] [Abstract][Full Text] [Related]
19. Nisin variants: What makes them different and unique?
da Silva Oliveira W; Teixeira CRV; Mantovani HC; Dolabella SS; Jain S; Barbosa AAT
Peptides; 2024 Jul; 177():171220. PubMed ID: 38636811
[TBL] [Abstract][Full Text] [Related]
20. Suicin 90-1330 from a nonvirulent strain of Streptococcus suis: a nisin-related lantibiotic active on gram-positive swine pathogens.
LeBel G; Vaillancourt K; Frenette M; Gottschalk M; Grenier D
Appl Environ Microbiol; 2014 Sep; 80(17):5484-92. PubMed ID: 24973067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
